Gold futures are edging higher on Friday after counter-trend buyers came in to defend the low of its 10-day range. Nonetheless, the market is set to finish lower for a second consecutive week as promising COVID-19 vaccine trials and U.S. Treasury Secretary Steven Mnuchin’s call to end the Federal Reserve’s key pandemic lending program eroded the bullion’s safe-haven appeal to some.
At 12:31 GMT, December Comex gold futures are trading $1863.80, up $2.30 or +0.12%. COVID-19 Vaccine Pressure
Gold took a hit earlier in the week after Moderna became the second U.S. drugmaker to announce late-stage successful vaccine trials. This follows a similar announce from Pfizer early last week. In a follow-up move, the U.S. drugmaker said on Wednesday that it was set to apply for emergency U.S. authorization after final results from its vaccine trial showed a 95% success rate with two months of safety data. Federal Reserve Stands […]
November 21, 2020 (updated November 21, 2020) Published by StockMan